Yusuke Mizuuchi
Overview
Explore the profile of Yusuke Mizuuchi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
66
Citations
604
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miyakita H, Yamamoto S, Uchino M, Hiroki I, Okabayashi K, Shiro O, et al.
Colorectal Dis
. 2025 Mar;
27(3):e70044.
PMID: 40025818
Aim: Ulcerative colitis (UC) is a known contributor to the development of colitis-associated cancer (CAC), although the exact mechanism remains to be elucidated. CAC typically presents as a flat type...
2.
Manabe T, Mizuuchi Y, Okuyama K, Takesue S, Fujimoto T, Tanaka F, et al.
Tech Coloproctol
. 2025 Feb;
29(1):66.
PMID: 39951184
Purpose: Tension-free ileal pouch-anal anastomosis (IPAA) in restorative proctocolectomy (RPC) for ulcerative colitis (UC) and familial adenomatous polyposis (FAP) is important for avoiding anastomotic complications. We have employed the elongation...
3.
Fujimoto T, Tamura K, Nagayoshi K, Mizuuchi Y, Okada Y, Osajima S, et al.
Surg Today
. 2025 Jan;
PMID: 39789347
Purpose: This study aimed to evaluate the relationship between the quantity and quality of subcutaneous fat and prognosis following colorectal cancer resection. Method: We conducted a retrospective analysis of the...
4.
Tsutsumi C, Ohuchida K, Tsutsumi H, Shimada Y, Yamada Y, Son K, et al.
Cancer Lett
. 2024 Dec;
611:217412.
PMID: 39722406
Therapies targeting HER2 are the standard treatment for HER2-positive gastric cancer (GC). Trastuzumab, a monoclonal antibody against HER2, exerts anti-tumor activity through cell growth regulation and antibody-dependent cellular cytotoxicity (ADCC)....
5.
Katayama N, Ohuchida K, Son K, Tsutsumi C, Mochida Y, Noguchi S, et al.
Gastric Cancer
. 2024 Dec;
28(2):211-227.
PMID: 39722065
Background: Gastric cancer (GC) shows limited response to immune checkpoint inhibitors due to its complex tumor immune microenvironment (TIME). This study explores the functions of various immune cells in the...
6.
Zhang J, Mizuuchi Y, Ohuchida K, Hisano K, Shimada Y, Katayama N, et al.
Cancer Sci
. 2024 Dec;
116(2):500-512.
PMID: 39623744
Patients with colorectal cancer (CRC) following renal transplantation require long-term immunosuppressants to prevent graft rejection. However, the impact of these immunosuppressants on the tumor immune microenvironment and the roles of...
7.
Tamura K, Fujimoto T, Shimizu T, Nagayoshi K, Mizuuchi Y, Hisano K, et al.
Surg Endosc
. 2024 Sep;
38(12):7139-7151.
PMID: 39347960
Background: Patients with a history of colorectal cancer (CRC) are at increased risk of developing secondary synchronous/metachronous CRCs. The role of minimally invasive surgery (MIS) for multiple CRCs remains unclear....
8.
Uehara K, Yamada S, Mizuuchi Y, Kitazono T, Nakano T
CEN Case Rep
. 2024 Sep;
PMID: 39297893
No abstract available.
9.
Fujimoto T, Tamura K, Nagayoshi K, Mizuuchi Y, Oh Y, Nara T, et al.
Surg Today
. 2024 Jun;
55(1):78-89.
PMID: 38880803
Purpose: To establish if osteosarcopenia is related to postoperative complications, prognosis, and recurrence of colorectal cancer (CRC) after curative surgery. Methods: The clinical data of 594 patients who underwent curative...
10.
Fujimoto T, Tamura K, Nagayoshi K, Mizuuchi Y, Goto F, Matsuda H, et al.
Surg Today
. 2024 Mar;
54(10):1184-1192.
PMID: 38548999
Purpose: This study explored the difficulty factors in robot-assisted low and ultra-low anterior resection, focusing on simple measurements of the pelvic anatomy. Methods: This was a retrospective analysis of the...